观察血液透析联合血液灌流治疗血液透析患者肾性骨病的临床疗效

To Observe the Clinical Effect of Hemodialysis Combined with Hemoperfusion on Hemodialysis Patients with Renal Osteopathy

目的观察分析血液透析+血液灌流治疗血液透析患者肾性骨病的临床疗效。方法选取2014年10月至2017年10月入我院接受诊疗的120例血液透析肾性骨病患者作为研究对象,回顾性分析其临床资料,以患者及其家属知情自愿为前提,根据不同治疗方案将病例分为对照组(50例)、联合组(70例)两个组别,对照组给予患者常规血液透析治疗,联合组在此基础上再行血液灌流治疗,对比两组对象治疗效果差异。结果治疗后联合组患者血磷、血钙及血iPTH水平均优于对照组,其中血磷、血iPTH水平差异有统计学意义(P<0.05);联合组患者治疗总有效率97.1%明显高于对照组的78.0%(χ~2=11.064,P=0.000)。结论血液透析联合血液灌流治疗血液透析肾性骨病可显著改善患体血磷、血iPTH水平,临床效果良好,应用价值高。

Objective To observe and analyze the clinical effect of hemodialysis ＋ hemoperfusion on hemodialysis patients with renal osteopathy. Methods From January 2014 to October 2017, 120 patients with hemodialysis and renal osteodystrosis admitted to our hospital from October 2014 to October 2017 were selected as the research objects. The clinical data were retrospectively analyzed. Based on the informed consent of patients and their families, The patients were divided into two groups： control group（50 cases） and combination group（70 cases）. Patients in the control group were given conventional hemodialysis treatment. On the basis of this, Effect difference. Results The levels of serum phosphorus and blood iPTH were significantly different（P〈0.05）. The total effective rate was 97.1% in the combined group 78.0% higher than the control group（χ~2=11.064, P=0.000）. Conclusion Hemodialysis combined with hemoperfusion for hemodialysis and renal osteodystrophy can significantly improve the level of blood phosphorus and blood iPTH, and has good clinical effect and high application value.